Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahtab Samimi

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Drugs & Aging|July 23, 2020
Real-World Effectiveness and Safety of Apremilast in Older Patients with PsoriasisCéline Phan, Nathalie Beneton, Juliette Delaunay, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2024
Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare databaseLaurent Mortier, Astrid Blom, Benoît van Hille, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 24, 2018
Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomasThibault Kervarrec, Anne Tallet, Elodie Miquelestorena-Standley, et al.
Cancers|July 29, 2023
Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC)Charlée Nardin, Aymeric Hennemann, Kadiatou Diallo, et al.
Pathology|October 25, 2024
Re-evaluation of the concept of basaloid follicular hamartoma associated with naevoid basal cell carcinoma syndrome: a morphological, immunohistochemical and molecular studySimon Barbieux, Fanélie Jouenne, Marie-Christine Machet, et al.
Oncoimmunology|December 10, 2020
Skin inflammatory response and efficacy of anti-epidermal growth factor receptor therapy in metastatic colorectal cancer (CUTACETUX)David Tougeron, Sheik Emambux, Laure Favot, et al.
Journal for Immunotherapy of Cancer|March 14, 2025
Optimization of Adcitmer, a Monomethyl-Auristatin E bearing antibody-drug conjugate for the treatment of CD56-expressing cancersAurelie Drouin, Laurine Durand, Clara Esnault, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 16, 2019
Morphologic and immunophenotypical features distinguishing Merkel cell polyomavirus-positive and negative Merkel cell carcinomaThibault Kervarrec, Anne Tallet, Elodie Miquelestorena-Standley, et al.
American Journal of Clinical Dermatology|October 8, 2024
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 StudyLaurent Mortier, Lisa Villabona, Ben Lawrence, et al.
Journal of the American Academy of Dermatology|August 25, 2025
Genomic and clinical characterization of anogenital basal cell carcinoma: a retrospective and prospective cohort studyLea Dousset, Andrey A Yurchenko, Johan Chanal, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Drugs & Aging|July 23, 2020
Real-World Effectiveness and Safety of Apremilast in Older Patients with PsoriasisCéline Phan, Nathalie Beneton, Juliette Delaunay, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2024
Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare databaseLaurent Mortier, Astrid Blom, Benoît van Hille, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 24, 2018
Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomasThibault Kervarrec, Anne Tallet, Elodie Miquelestorena-Standley, et al.
Cancers|July 29, 2023
Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC)Charlée Nardin, Aymeric Hennemann, Kadiatou Diallo, et al.
Pathology|October 25, 2024
Re-evaluation of the concept of basaloid follicular hamartoma associated with naevoid basal cell carcinoma syndrome: a morphological, immunohistochemical and molecular studySimon Barbieux, Fanélie Jouenne, Marie-Christine Machet, et al.
Oncoimmunology|December 10, 2020
Skin inflammatory response and efficacy of anti-epidermal growth factor receptor therapy in metastatic colorectal cancer (CUTACETUX)David Tougeron, Sheik Emambux, Laure Favot, et al.
Journal for Immunotherapy of Cancer|March 14, 2025
Optimization of Adcitmer, a Monomethyl-Auristatin E bearing antibody-drug conjugate for the treatment of CD56-expressing cancersAurelie Drouin, Laurine Durand, Clara Esnault, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 16, 2019
Morphologic and immunophenotypical features distinguishing Merkel cell polyomavirus-positive and negative Merkel cell carcinomaThibault Kervarrec, Anne Tallet, Elodie Miquelestorena-Standley, et al.
American Journal of Clinical Dermatology|October 8, 2024
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 StudyLaurent Mortier, Lisa Villabona, Ben Lawrence, et al.
Journal of the American Academy of Dermatology|August 25, 2025
Genomic and clinical characterization of anogenital basal cell carcinoma: a retrospective and prospective cohort studyLea Dousset, Andrey A Yurchenko, Johan Chanal, et al.
Pageof 9